Wang, L., Rao, C., Wang, Q., Huang, K., Liu, L., Zhao, J., Wu, Y., Chen, J., Qian, J., Lu, H., Pan, S., Nie, L., Tang, H., Dong, H., Jia, S., Zang, Y., Chu, T., Su, C. (2026). Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial. Nature Communications. https://doi.org/10.1038/s41467-026-74241-3